SEC Form 4 · accession 0001144204-19-000726
USANA HEALTH SCIENCES INC · USNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Myron W Wentz
Director
Period of report
Jan 2, 2019
Accepted (ET)
Jan 4, 2019 · 7:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000896264
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3,F4 | Jan 2, 2019 | S | 7,131 | $116.25 | D | 9,918,483 | I | Shares owned of record by Gull Global Limited |
| Common StockF3,F5,F4 | Jan 2, 2019 | S | 2,600 | $117.00 | D | 9,915,883 | I | Shares owned of record by Gull Global Limited |
| Common StockF3,F6,F4 | Jan 2, 2019 | S | 200 | $117.68 | D | 9,915,683 | I | Shares owned of record by Gull Global Limited |
| Common StockF3,F7,F4 | Jan 3, 2019 | S | 7,096 | $113.07 | D | 9,908,587 | I | Shares owned of record by Gull Global Limited |
| Common StockF3,F8,F4 | Jan 3, 2019 | S | 2,316 | $113.86 | D | 9,906,271 | I | Shares owned of record by Gull Global Limited |
| Common StockF3,F9,F4 | Jan 3, 2019 | S | 700 | $115.25 | D | 9,905,571 | I | Shares owned of record by Gull Global Limited |
| Common StockF4 | Jan 3, 2019 | S | 100 | $115.97 | D | 9,905,471 | I | Shares owned of record by Gull Global Limited |
| Common StockF3,F10,F4 | Jan 4, 2019 | S | 1,700 | $113.17 | D | 9,903,771 | I | Shares owned of record by Gull Global Limited |
| Common StockF3,F11,F4 | Jan 4, 2019 | S | 3,223 | $114.23 | D | 9,900,548 | I | Shares owned of record by Gull Global Limited |
| Common StockF3,F12,F4 | Jan 4, 2019 | S | 4,474 | $115.00 | D | 9,896,074 | I | Shares owned of record by Gull Global Limited |
| Common StockF3,F13,F4 | Jan 4, 2019 | S | 160 | $116.11 | D | 9,895,914 | I | Shares owned of record by Gull Global Limited |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F10Weighted average price. Price range in multiple transactions was $112.67 to $113.66, inclusive.
- F11Weighted average price. Price range in multiple transactions was $113.71 to $114.69, inclusive.
- F12Weighted average price. Price range in multiple transactions was $114.71 to $115.67, inclusive.
- F13Weighted average price. Price range in multiple transactions was $116.10 to $116.13, inclusive.
- F2Weighted average price. Price range in multiple transactions was $115.64 to $116.60, inclusive.
- F3The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.
- F4The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz.
- F5Weighted average price. Price range in multiple transactions was $116.64 to $117.61, inclusive.
- F6Weighted average price. Price range in multiple transactions was $117.65 to $117.70, inclusive.
- F7Weighted average price. Price range in multiple transactions was $112.53 to $113.51, inclusive.
- F8Weighted average price. Price range in multiple transactions was $113.57 to $114.46, inclusive.
- F9Weighted average price. Price range in multiple transactions was $114.67 to $115.56, inclusive.